Workflow
Anixa Biosciences(ANIX) - 2019 Q3 - Quarterly Report
ANIXAnixa Biosciences(ANIX)2019-09-06 21:01

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 Commission file number 0-11254 ANIXA BIOSCIENCES, INC. | --- | --- | --- | |-------------------------------------------------|--------------------------------------------------------|-----------------------------| | | (Exact name of registrant as specified in its charter) | | | Delaware (State or ...